| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $46,911,464 ) (Continued on the next page) |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM158165 | Structural and Functional Studies of Chromatin | 000 | 1 | NIH | 4/28/2025 | $667,480 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA262790 | The Role of Immature Tumor Subpopulations In Pediatric Rhabdomyosarcoma | 000 | 4 | NIH | 2/13/2025 | $374,693 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI192221 | [18F]fluoromannitol: A novel imaging agent to delineate osteomyelitis in sickle cell disease | 000 | 1 | NIH | 2/26/2025 | $894,735 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA260175 | XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION | 000 | 4 | NIH | 2/13/2025 | $374,693 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21NS142525 | Investigating the role of RHOBTB2 in DEE to develop novel therapies | 000 | 1 | NIH | 2/28/2025 | $277,500 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | F32AI191456 | Defining mechanistic drivers of impaired B cell response to influenza A virus vaccine under conditions of obesity | 000 | 1 | NIH | 5/1/2025 | $73,828 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R13OD037166 | Workshop on the Pathology of Mouse Models for Human Disease | 000 | 1 | NIH | 5/13/2025 | $22,000 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM141357 | Molecular Mechanisms Underlying Mammalian NADPH Oxidase Activation and Regulation | 000 | 5 | NIH | 2/20/2025 | $323,100 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM141947 | Pharmacogenetics of Nucleobase and Nucleoside Analog Drugs | 001 | 5 | NIH | 2/19/2025 | $516,960 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI153138 | Robust immune tolerance conferred by Foxp3 transcriptional regulation | 000 | 5 | NIH | 12/18/2024 | $435,288 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01MH139498 | Thalamocortical disruption as a convergence point for schizophrenia risks | 000 | 1 | NIH | 4/3/2025 | $735,932 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA237311 | EPIGENETIC REPROGRAMMING OF T CELL EXHAUSTION TO ENHANCE TUMOR IMMUNOTHERAPY | 000 | 6 | NIH | 4/7/2025 | $465,506 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35NS142868 | Dynamic RNA-Protein Assemblies and Neurological Disease | 000 | 1 | NIH | 4/17/2025 | $897,250 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35NS142868 | Dynamic RNA-Protein Assemblies and Neurological Disease | 001 | 1 | NIH | 4/18/2025 | $0 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI140761 | Transcriptional and metabolic heterogeneity in T cell differentiation | 001 | 7 | NIH | 3/28/2025 | $546,000 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA241452 | Pathogenesis of ETV6-Related Acute Lymphoblastic Leukemia | 000 | 4 | NIH | 4/1/2025 | $211,268 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R37AI044828 | Survival Function of the Fadd-Caspase-8-Flip Complex - MERIT Extension | 000 | 27 | NIH | 4/16/2025 | $455,000 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM118041 | Regulation of xenobiotic receptors PXR and CAR, and CYP3A: implications in drug disposition | 001 | 10 | NIH | 3/25/2025 | $403,875 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI124346 | Innate immune signaling and stress response | 000 | 10 | NIH | 4/3/2025 | $538,500 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01HG013981 | Deciphering the underlying structure of the glucocorticoid gene regulatory network | 001 | 1 | NIH | 4/23/2025 | $69,355 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01HG013981 | Deciphering the underlying structure of the glucocorticoid gene regulatory network | 000 | 1 | NIH | 3/24/2025 | $745,013 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA172152 | Role of the SWI/SNF complex in tumor suppression | 003 | 13 | NIH | 4/4/2025 | $405,401 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA194057 | Transporters and Medulloblastoma | 000 | 10 | NIH | 3/14/2025 | $365,852 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | UM1CA081457 | Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors | 000 | 25 | NIH | 4/17/2025 | $3,793,439 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R37CA286444 | Dissecting high-risk cell states in neuroblastoma | 000 | 2 | NIH | 2/14/2025 | $533,298 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | T32AI106700 | Training in the Design and Development of Infectious Disease Therapeutics | 000 | 10 | NIH | 4/24/2025 | $251,443 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA113794 | The function of Snf5 (SMARCB1), an epigenetic tumor suppressor | 000 | 21 | NIH | 11/21/2024 | $381,159 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U24CA055727 | Childhood Cancer Survivorship Study | 001 | 31 | NIH | 3/5/2025 | $3,024,600 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R25CA023944 | PEDIATRIC ONCOLOGY EDUCATION (YEARS 38 - 42) | 000 | 41 | NIH | 4/30/2025 | $388,801 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA289881 | Targetable epigenetic modifiers that promote neuroblastoma malignancy and plasticity | 000 | 1 | NIH | 1/10/2025 | $718,113 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI128756 | Bioactivities of pneumococcal cell wall in neuropathogenesis | 000 | 9 | NIH | 1/21/2025 | $441,350 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AG075869 | REGULATION OF PROTEOSTASIS AND TAUOPATHY BY MALTOSE-INDUCED SIGNALING | 000 | 2 | NIH | 1/23/2025 | $416,250 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R37AI105887 | Metabolic checkpoint in dendritic cell subsets and adaptive immunity | 000 | 12 | NIH | 12/3/2024 | $455,000 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM157243 | Deciphering the genetic regulation of bacterial heterogeneity in response to antibiotic stress using single-cell transcriptomics | 000 | 1 | NIH | 12/24/2024 | $462,500 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R21AI178085 | Trivalent Live Attenuated Vaccines for Bacterial Acute Otitis Media | 000 | 2 | NIH | 12/9/2024 | $220,675 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01EY037117 | The Role of Müller Glia in Acute and Chronic Response to Stress, Injury, and Disease in the Retina | 000 | 1 | NIH | 1/15/2025 | $606,034 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01DC021511 | Sensory-evoked adenosine release in cortical plasticity | 000 | 2 | NIH | 5/6/2025 | $561,784 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA290805 | Targeting the chromatin binding domains of BPTF for neuroblastoma epigenetic therapy | 000 | 1 | NIH | 12/30/2024 | $738,024 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | T32HL176447 | Basic and Translational Research Training in Pediatric Classical Hematology | 000 | 1 | NIH | 12/26/2024 | $252,285 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K99DK134844 | Hematopoietic stem cell defects in Diamond-Blackfan Anemia | 000 | 2 | NIH | 4/8/2025 | $90,000 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS121114 | Understanding the sequence and structural determinants of phase behavior of ALS-causing proteins | 000 | 5 | NIH | 2/20/2025 | $561,572 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI168214 | Consequences of Direct Viral-Bacterial Interactions | 000 | 4 | NIH | 12/9/2024 | $487,212 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K08CA255569 | WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor | 000 | 5 | NIH | 12/12/2024 | $194,741 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI170765 | Targeting NuoD for the treatment of H. pylori | 000 | 3 | NIH | 4/15/2025 | $844,980 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01MH136215 | Cooperative dysfunction of thalamocortical and cerebellar inputs to the auditory cortex in 22q11.2 deletion syndrome model of schizophrenia. | 001 | 1 | NIH | 11/29/2024 | $9,436 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01MH136215 | Cooperative dysfunction of thalamocortical and cerebellar inputs to the auditory cortex in 22q11.2 deletion syndrome model of schizophrenia. | 000 | 1 | NIH | 11/27/2024 | $721,599 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS139519 | Polarity Signals Coordinate Neuronal Differentiation & Nuclear Organization | 000 | 1 | NIH | 11/22/2024 | $676,388 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01NS121249 | Improving genetically engineered T cells for medulloblastomas | 000 | 5 | NIH | 3/11/2025 | $400,298 |
| | 2025 | 2025 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI131703 | Regulation of T cell memory in tissue immunity | 000 | 6 | NIH | 11/13/2024 | $538,352 |
|
